Antifungal drug shortage in India amid an increase in invasive fungal functions during the coronavirus disease 2019 (COVID-19) pandemic.

Arun, Ashitha B; Hasan, Mohammad Mehedi; Rackimuthu, Sudhan; Ullah, Irfan; Mir, Tanveer; Saha, Anwesha

Arun, Ashitha B; Hasan, Mohammad Mehedi; Rackimuthu, Sudhan; Ullah, Irfan; Mir, Tanveer; Saha, Anwesha.

Afiliação

Arun AB; St Joseph's College, Bangalore, India.
Hasan MM; Department of Biochemistry and Molecular Biology, Faculty of Life Science, Mawlana Bhashani Science and Technology University, Tangail, Bangladesh.
Rackimuthu S; Father Muller Medical College, Mangalore, Karnataka, India.
Ullah I; Kabir Medical College, Gandhara University, Peshawar, Pakistan.
Mir T; Department of Internal Medicine, Wayne State University, Detroit, Michigan, United States.
Saha A; Department of Biotechnology; Heritage Institute of Technology, Kolkata, West Bengal, India.

Infect Control Hosp Epidemiol ; 43(12): 1965-1966, 2022 12.

Article em En | MEDLINE | ID: mdl-34553680

Assuntos

COVID-19; Pandemias; Humanos; COVID-19/epidemiologia; Antifúngicos/uso terapêutico; SARS-CoV-2; Índia/epidemiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pandemias / COVID-19 Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Infect Control Hosp Epidemiol Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google